期刊文献+

慢性肾病患者肾小球滤过率评估方程诊断价值Meta分析 被引量:4

Diagnostic value of evaluating glomerular filtration rate equations in patients with chronic kidney disease:a Meta-analysis
下载PDF
导出
摘要 目的采用Meta分析方法评价eGFR方程对评估慢性肾病肾小球滤过率的诊断价值。方法计算机检索The Cochrane Libray(2015年第1期)MEDLINE、PubMed、EMbase、CBM、CNKI、万方数据,查找有关慢性肾病患者eGFR方程诊断价值的研究,检索时限均为建库至2016年6月。两位研究者按纳入与排除标准独立筛选文献、提取资料和评价质量后,采用RevMan 5.2软件、Meta-Disc软件进行Meta分析。结果最终纳入22个研究观察对象,共纳入6348例CKD患者。Meta分析结果显示:不同eGFR方程与参考方法 r GFR的测定结果具有较好的相关性,CysC-GFR方程GFR均值比参考方法低[MD=-2.59,95%CI(-5.22,0.04),P=0.05]。CKD-EPI(Cr-GFR)方程GFR均值与对照组差异无统计学意义[MD=-0.49,95%CI(-1.22,2.20),P=0.57]。MDRD方程GFR均值与参考方法差异无统计学意义[MD=--3.68,95%CI(-9.87,2.51),P=0.24]。C-G方程GFR均值比参考方法偏高[MD=2.20,95%CI(0.47,3.93),P=0.01]。CKD-EPI(Cr-CysC)方程GFR均值比参考方法偏低[MD=-3.95,95%CI(-5.79,-2.10),P<0.0001]。从MDRD方程亚组分析看,GFR60-89ml/min、GFR30-59ml/min,CKD分期GFR实际评估效应最好,GFR>90ml/min,出现高值区低估现象。结论 eGFR方程与参考方法测定rGFR具有良好的相关性,eGFR方程CKDEPI(Cr-GFR)、MDRD与参考方法 GFR平均水平无差异,但是不同CKD分期eGFR评估水平有偏倚。鉴于eGFR方程评估参数不统一,异质性较大,尚需进一步验证。 Objective To evaluate eGFR evaluation equation of the diagnostic value of glomerular filtration rate in chronic kidney disease by using the Meta analysis method. Methods We comprehensibly searched databases including The Cochrane Library(Issue 1,2015),MEDLINE,PubMed,EMbase,CBM,CNKI,Wan Fang Data from inception to June 2016,collected studies about the diagnostic value of evaluating glomerular filtration rate equations in Patients with chronic kidney disease. Two researchers independently screened the literature,extracted data,and evaluated the quality of the research by inclusion and exclusion criteria. And then meta analysis was carried out by using RevMan 5.2 software and Meta-Disc software. Results A total of 22 studies were selected finally,6348 cases of CKD patients were enrolled in this study. Meta analysis results show that,the different eGFR estimation equation and the reference method r GFR the determination results have good correlation,GFR value of Cys C-GFR equation is lower than that of reference method [MD=-2.59,95%CI(-5.22,0.04),P=0.05]. GFR value has no significant difference between the CKD-EPI(Cr-GFR) and the reference method [MD =-0.49,95% CI(-1.22,2.20),P =0.57]. GFR value has no significant difference between the MDRD equation and the reference method [MD=--3.68,95%CI(-9.87,2.51),P=0.24]. GFR value of C-G equation is higher than that of reference method [MD=2.20,95%CI(0.47,3.93),P=0.01]. GFR value of CKD-EPI(CrCys C) equation is lower than that of reference method[MD=-3.95,95%CI(-5.79,-2.10),P〈0.0001]. From the analysis of MDRD equation subgroup we can know that,GFR60-89ml/min,GFR30-59ml/min,CKD staging GFR the actual assessment of the effect is the best,GFR〉90ml/min,has a high value area of underestimated phenomenon. Conclusion The eGFR equation and the reference method for the determination of rGFR have good correlation. The average level of GFR has no difference between eGFR estimating equation CKD-EPI(Cr-GFR),MDRD and the reference method,however,the level of eGFR has a bias in different CKD stages. Given the not unified evaluation parameters and large heterogeneous of the eGFR equation,we still need to further verify.
出处 《实验与检验医学》 CAS 2017年第3期324-329,共6页 Experimental and Laboratory Medicine
基金 上海宝山区科委课题 编号:12-E-5
关键词 慢性肾病 肾小球滤过率 肌酐 胱抑素C Chronic kidney disease(CKD) Glomerular filtration rate(GFR) Creatinine(Cr) Cystatin C(CysC)
  • 相关文献

参考文献9

二级参考文献135

  • 1马迎春,左力,王梅,周玉红,张春丽,徐国宾,王海燕.肾小球滤过率评估方程在慢性肾脏病不同分期中的适用性[J].中华内科杂志,2005,44(4):285-289. 被引量:82
  • 2史浩,陈楠,张文,任红,徐耀文,沈平雁,王伟铭,俞海瑾,李晓,冯晓蓓.简化MDRD公式预测慢性肾病患者肾小球滤过率的应用评价及校正[J].中国实用内科杂志,2006,26(5):665-669. 被引量:85
  • 3全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:697
  • 4Ma YC,Zuo L,Chen JH,Luo Q,Yu XQ,Li Y,et al.Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.J Am Soc Nephrol 2006;17:2937-2944.
  • 5Rossing P,Rossing K,Gaede P,Pedersen O,Pairing HH.Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.Diabetes Care 2006;29:1024-1030.
  • 6Hojs R,Bevc S,Ekart R,Gorenjak M,Puklavec L.Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.Nephrol Dial Transplant 2006;21:1855-1862.
  • 7Chudleigh RA,Ollerton RL,Dunseath G,Peter R,Harvey JN,Luzio S,et al.Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes.Diabetologia 2009;52:1274-1278.
  • 8Myers GL,Miller WG,Coresh J,Fleming J,Greenberg N,Greene T,et al.Recommendations for improving serum creatinine measurement:a report from the Laboratory Working Group of the National Kidney Disease Education Program.Clin Chem 2006;52:5-18.
  • 9Zhang CL,Li Q,Zuo L,Cui Y,Wang YF,Guo FQ,et al.Measurement of glomerular filtration rate with renal dynamic imaging:comparison with two-sample method.J Peking Univ (Chin) 2004;36:612-615.
  • 10Itoh K.Comparison of methods for determination of glomerular filtration rate:Tc-99m-DTPA renography,predicted creatinine clearance method and plasma sample method.Ann Nucl Med 2003;17:561-565.

共引文献74

同被引文献20

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部